Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation
Reference29 articles.
1. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Version 2. Ft Washington, PA: NCCN; 2014.
2. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: Results from a single institution series;Tilki;Urol Oncol,2011
3. Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: The predictive role of age and prostate-specific antigen;Isariyawongse;Urology,2008
4. Significant upgrading affects a third of men diagnosed with prostate cancer: Predictive nomogram and internal validation;Chun;BJU Int,2006
5. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology;Chun;Eur Urol,2006
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral Center;Cancers;2024-06-04
2. Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?;International Urology and Nephrology;2024-03-30
3. Multivariate logistic regression analysis of the clinical factors influencing locally advanced prostate cancer;Translational Cancer Research;2024-02
4. The impact of prognostic group classification on prostate cancer progression in intermediate-risk patients according to the European Association of Urology system: results in 479 patients treated with robot-assisted radical prostatectomy at a single tertiary referral center;Therapeutic Advances in Urology;2024-01
5. ENOX1, CCDC122ANDLACC1ROLE IN PROGRESSION OF PROSTATE CANCER;2023-10-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3